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In this issue of Cell Stem Cell, Karimi et al. (2011) show that DNA methylation and histone H3 lysine 9 trime-
thylation (H3K9me3) have distinct genomic targets in mouse ESCs. In particular, loss of H3K9me3 leads to
derepression of select endogenous retroviruses and subsequent ectopic transcription of adjacent genes.Epigenetic mechanisms, including DNA
methylation, histone tail modifications,
and noncoding RNAs (nc-RNAs) such as
microRNA, lincRNAs, and piRNAs, can
stably influence gene expression without
changing the underlying DNA sequence.
While each type of epigenetic mechanism
can exert a unique influence on a subset
of genes, they collectively act in concert
with core transcriptional circuitry to com-
pose the transcriptome landscape in dif-
ferent cell types (Fouse et al., 2008). Alter-
ation of one epigenetic factor may also
lead to changes in another epigenetic
pathway. For example, both DNA methyl-
ation and repressive histone modifica-
tions (including H3 deacetylation and
lysine 9 methylation) are associated with
repressive chromatin remodeling in gene
silencing (Cedar and Bergman, 2009).
Loss of histone H3K9me2 modification in
the absence of lysine methyltransferase
G9a can cause a significant reduction of
DNA methylation in multiple genomic re-
gions, including promoters, satellite re-
peats, and retrotransposons (Dong et al.,
2008).
Genetic studies indicate that DNA and
histonemethylation are essential for animal
development; mutant mice lacking either
DNA methyltransferase (DNMT) or histone
lysinemethyltransferases (KMTase) exhibit
a lethal phenotype. However, DNMTs and
KMTases are not essential for self-renewal
of pluripotent mouse embryonic stem
cells (mESCs): either single Dnmt mutant
ESCs (Dnmt1/, Dnmt3a/, Dnmt3b/)
or triple Dnmt1/3a/3b knockout (TKO)
mESCs can proliferate and self-renew
normally (Hutnick et al., 2010; Tsumura
et al., 2006). Similarly, mESCs deficient
for lysine 9 KMTase (SUV39H1, SUV39H2,
G9a,GLP, andSETDB1) can survive (Dong
et al., 2008;Matsui et al., 2010; Roweet al.,604 Cell Stem Cell 8, June 3, 2011 ª2011 Els2010). The availability of mESCs that ex-
hibit deficits in DNA methylation and his-
tone modifications provides a unique op-
portunity to understand how multiple
layers of epigenetic factors are involved in
regulating gene expression in pluripotent
ESCs.
In this issue of Cell Stem Cell, Lorincz
and colleagues focus on the shared and
distinct functions between DNA methyla-
tion and H3K9me3, reporting a compre-
hensive comparison between the two
epigenetic mechanisms in mouse ESCs
(Karimi et al., 2011). The authors per-
formed mRNA-Seq and ChIP-Seq of
H3K9me3 in wild-type, SETDB1 KO, and
DNMT TKO mESCs with the goal to
assess the effect of DNA methylation
and H3K9me3 on mRNA transcriptome.
Consistent with previous findings (Matsui
et al., 2010), the authors found that both
epigenetic pathways appear to be inde-
pendent from each other. For example,
at SETDB1-bound regions, DNMT TKO
cells showminor loss of H3K9me3 enrich-
ment, whereas nearly 80% of H3K9me3
sites are lost in SETDB1 KO mESCs
compared with control. In the reverse
comparison, the authors found that prox-
imal promoter regions bound by SETDB1
are frequently unmethylated. However,
the DNA methylation data set used in
this study only covers an 4 kb region
surrounding annotated proximal gene
promoters (Myant et al., 2011); therefore,
the overlap of DNA methylation and
H3K9me3 at many genomic regions, in-
cluding gene body, repeat elements, and
other interesting intergenic regions, re-
main to be investigated.
Compared with control, derepressed
genes in DNMT TKO and SETDB1 KO
have little overlap, likely reflecting their
distinct genomic localization. However,evier Inc.there is a small subset of genes that is
derepressed in both KO cell lines, genes
predominantly involved in germline devel-
opment. Thus, both DNA methylation and
H3K9me3 are required for the silencing of
these germline-related genes. While the
authors demonstrate reduced levels of
H3K9me3 in DNMT TKO cells at these
genes, it would be of interest to determine
whether these loci still retain or lose DNA
methylation in SETDB1 KO cells. Never-
theless, derepression of this small subset
of genes in both DNMT TKO and SETDB1
KO cells indicates that DNA methylation
and H3K9me3 may be involved in the
same regulatory pathway.
Previous studies have shown that
H3K9me3, established by SETDB1, is im-
portant for silencing subfamilies of endog-
enous retroviruses (ERVs), a class of
repeat element found throughout the
mammalian genome (Matsui et al., 2010;
Rowe et al., 2010; Hutnick et al., 2010).
ERVs are strictly inactivated during em-
bryogenesis to prevent insertional muta-
tions during early development (Rowe
and Trono, 2011). With the powerful tech-
nique of RNA-Seq, the authors now identi-
fied an entire slew of ERV subfamilies,
predominantly in class I and class II, dere-
pressed exclusively in SETDB1 KO cell
lines. The proximal regions flanking ERV
elements showed consistent and marked
loss of H3K9me3 in SETDB1 KO, indi-
cating a direct and genome-wide role for
SETDB1 regulating ERVs. In contrast,
loss of DNA methylation in DNMT TKO
cells had minimal effects on ERV expres-
sion. Interestingly, double Dnmt1/Setdb1
knockdown in wild-type mESCs showed
synergistic effects only at IAPE-z repeat
element, suggesting DNA methylation
plays a minor role in silencing select retro-
viral elements in mESCs.
Figure 1. ERV Expression Promotes Ectopic Transcription of Adjacent Genes
Schematic illustrating the effects of H3K9me3 on ERV expression. (A) ERVs are silenced byH3K9me3, and
normal transcription occurs in wild-type mESCs. (B) Loss of H3K9me3 in SETDB1 KO mESCs triggers
ectopic activation of ERVs, promotes increased expression of adjacent genes, and generates chimeric
transcripts. (i) and (ii) are typical alternative 30 donor splice sites either in the ERV body (i) or in the 30
flanking genomic region (ii).
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this paper is that in SETDB1 KO mESCs,
ectopic activation of ERVs also triggers
transcription of nearby genes, especially
if the ERV element was within 5 kb
upstream of the transcription start site
(TSS). Notably, the authors were able
to identify ‘‘chimeric’’ transcripts—pair-
end reads mapping to both an ERV
element and a genic exon—associated
with ectopic transcript activation. Genes
with chimeric transcripts are typically notenriched in H3K9me3, unlike the up-
stream ERV element. Furthermore, genes
with chimeric transcripts ranked among
the highest expressed genes, indicating a
role for ERV in promoting adjacent pro-
tein-coding RNA expression (Figure 1).
This study provides an excellent ex-
ample of unraveling the many layers of
epigenetic mechanisms in silencing retro-
viral elements inmESCs by using SETDB1
KO and DNMT TKO cells. Many inter-
esting questions remain to be resolvedCell Stem Cwith regards to the specific actions of
each major epigenetic regulator in main-
taining genome stability in mammalian
cells. For example, would ectopic activa-
tion of ERVs in SETDB1 KO ESCs cause
an increase in retrotransposon insertions
and overall genomic instability? Are there
any specific changes in small RNAs or
nc-RNA transcriptome in DNMT TKO or
SETDB1 KO ESCs? Do H3K9me3 and
DNA methylation play similar roles in
gene silencing of ERVs in differentiated
somatic cells? With the increased analyt-
ical powers of high-throughput sequenc-
ing, we look forward to seeing more
exciting results in the near future.REFERENCES
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